- Home
- DNTH vs SBET Comparison
DNTH vs SBET Comparison
Compare DNTH & SBET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DNTH | SBET |
|---|---|---|
| Founded | 2015 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.9B |
| IPO Year | N/A | 1997 |
Fundamental Metrics
Financial Performance| Metric | DNTH | SBET |
|---|---|---|
| Price | $45.90 | $10.13 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 4 |
| Target Price | ★ $68.88 | $27.00 |
| AVG Volume (30 Days) | 811.5K | ★ 7.6M |
| Earning Date | 03-10-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $3,078,000.00 | ★ $13,106,030.00 |
| Revenue This Year | N/A | $369.92 |
| Revenue Next Year | N/A | $5,690.82 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 239.01 |
| 52 Week Low | $13.37 | $2.26 |
| 52 Week High | $46.59 | $124.12 |
Technical Indicators
Market Signals| Indicator | DNTH | SBET |
|---|---|---|
| Relative Strength Index (RSI) | 62.86 | 48.32 |
| Support Level | $42.37 | $10.40 |
| Resistance Level | $46.59 | $11.07 |
| Average True Range (ATR) | 2.79 | 0.55 |
| MACD | 0.67 | 0.15 |
| Stochastic Oscillator | 93.35 | 57.14 |
Price Performance
Historical ComparisonAbout DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About SBET SharpLink Gaming Ltd.
SharpLink Gaming Inc is one of the world's largest publicly traded companies to adopt ETH as its primary treasury reserve asset - a move that aligns the Company with the future of digital capital and gives investors direct exposure to Ethereum, the world's smart-contract platform and second largest digital asset.